Gene · 406891
MIRLET7I: microRNA let-7i
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. MIRLET7I: microRNA let-7i. Genes, record 406891. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/406891
On this page
Gene
Proteins0
Reviewed human proteins whose Swiss-Prot entry states the gene.
None in this release.
Patents0
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
None in this release.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants997
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | MIRLET7I papers | Newest fiscal year |
|---|---|---|---|
| P30DK084567 | Mayo Center for Cell Signaling in Gastroenterology | 7 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 5 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 5 | 2025 |
| ZIACL002119 | Develop novel assays for assessing cellular and gene therapies | 5 | 2025 |
| P30CA014599 | Cancer Center Support Grant | 4 | 2025 |
| R01DK057993 | Pathophysiology of Biliary Disease | 4 | 2025 |
| U54MD007602 | Center for Translational Research in Health Disparities | 4 | 2025 |
| P30AI161943 | Texas Developmental Center for AIDS Research | 3 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 3 | 2025 |
| P30CA016056 | Roswell Park Cancer Center Support Grant | 3 | 2025 |
1 to 10 of 997Source NIH's project files
See all 997 nih grantsPapers2,321
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Expression of Concern to "MicroRNA let-7i induced autophagy to protect T cell from apoptosis by targeting IGF1R" [Biochem. Biophys. Res. Commun. 453 (2014) 728]. | Biochem Biophys Res Commun | 2026 | 42810895 | PubTator, text mining | PubMed |
| RETRACTION: Up-regulation of KISS1 as a Novel Target of Let-7i in Melanoma Serves as a Potential Suppressor of Migration and Proliferation In Vitro. | J Cell Mol Med | 2026 | 42708619 | PubTator, text mining | PubMed |
| RETRACTION: Dioscin-loaded zein nanoparticles alleviate lipopolysaccharide-induced acute kidney injury via the microRNA-let 7i signalling pathways. | IET Nanobiotechnol | 2026 | 42683936 | PubTator, text mining | PubMed |
| Circulating T cell-specific extracellular vesicles as biomarkers of acute cellular rejection after lung transplantation. | Am J Transplant | 2026 | 42061617 | PubTator, text mining | PubMed |
| Exogenous glucocorticoid dose impacts circulating microRNA expression in patients with adrenal insufficiency due to 21-hydroxylase deficiency. | Front Endocrinol (Lausanne) | 2026 | 41987891 | PubTator, text mining | PubMed |
| The Non-Coding Code: Silent Regulators of MEG3 and Let-7i-3p/5p in the Progression of Acute Lymphoblastic Leukemia. | Asian Pac J Cancer Prev | 2026 | 41945960 | PubTator, text mining | PubMed |
| Study of circulating MiRNA expression in myopic patients. | Int Ophthalmol | 2026 | 41870798 | PubTator, text mining | PubMed |
| C1RL-AS1/microRNA-424-5p/adrenoceptor β2 axis: A novel regulatory mechanism in lung adenocarcinoma associated with immune infiltration and prognosis. | PLoS One | 2026 | 41811864 | PubTator, text mining | PubMed |
| MicroRNA signatures associated with radioiodine refractoriness and tumor dedifferentiation in metastatic papillary thyroid carcinoma. | Endocrine | 2026 | 41801518 | PubTator, text mining | PubMed |
| Exosomal non-coding RNAs in autoimmune diseases: molecular mechanisms and potential applications. | Front Immunol | 2026 | 41798919 | PubTator, text mining | PubMed |
1 to 10 of 2,321
See all 2,321 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/406891
GET https://conductscience.org/api/genes/v1/406891/grants?page=2